|
periodontitis |
17 |
|
periodontal disease |
11 |
|
inflammation |
10 |
|
diagnosis |
9 |
|
systematic review |
9 |
|
tooth loss |
9 |
|
gene expression |
8 |
|
periodontal diseases |
8 |
|
dental implant |
7 |
|
randomized clinical trial |
7 |
|
randomized controlled clinical trial |
7 |
|
risk factors |
7 |
|
clinical trial |
6 |
|
connective tissue graft |
6 |
|
coronally advanced flap |
6 |
|
dental implants |
6 |
|
diagnostic accuracy |
6 |
|
diet |
6 |
|
gingival inflammation |
6 |
|
gingivitis |
6 |
|
human |
6 |
|
logistic models |
6 |
|
matrix metalloproteinase-8 |
6 |
|
meta-analysis |
6 |
|
root coverage |
6 |
|
sensitivity and specificity |
6 |
|
wound healing |
6 |
|
bone augmentation |
5 |
|
bone regeneration |
5 |
|
cardiac function |
5 |
|
diabetes mellitus |
5 |
|
echocardiography |
5 |
|
endothelial progenitor cell |
5 |
|
epidemiology |
5 |
|
guided tissue regeneration |
5 |
|
intrabony defects |
5 |
|
non-surgical periodontal therapy |
5 |
|
peri-implantitis |
5 |
|
periodontal health |
5 |
|
periodontal regeneration |
5 |
|
periodontal therapy |
5 |
|
prevalence |
5 |
|
prognosis |
5 |
|
smoking |
5 |
|
tetracycline |
5 |
|
type 2 diabetes |
5 |
|
aesthetics |
4 |
|
aggressive periodontitis |
4 |
|
animals |
4 |
|
bleeding on probing |
4 |
|
bone matrix - transplantation |
4 |
|
bone substitutes - therapeutic use |
4 |
|
bone transplantation - methods |
4 |
|
cattle |
4 |
|
cbct |
4 |
|
chewing gum |
4 |
|
chronic kidney disease |
4 |
|
collagen matrix |
4 |
|
dental enamel proteins - therapeutic use |
4 |
|
dental scaling |
4 |
|
disto-lingual root (dlr) |
4 |
|
enamel matrix proteins |
4 |
|
furcation |
4 |
|
furcation involvement |
4 |
|
guided bone regeneration |
4 |
|
guided tissue regeneration, periodontal - methods |
4 |
|
male |
4 |
|
masticatory dysfunction |
4 |
|
membranes, artificial |
4 |
|
morphology |
4 |
|
oral health |
4 |
|
oral hygiene |
4 |
|
oral-health-related quality of life |
4 |
|
pathogenesis |
4 |
|
patient-reported outcome measures |
4 |
|
periodontal surgery |
4 |
|
polymorphism |
4 |
|
prevention |
4 |
|
regeneration |
4 |
|
renal function |
4 |
|
risk assessment |
4 |
|
screening |
4 |
|
self-reported questionnaire |
4 |
|
stage iv |
4 |
|
therapy |
4 |
|
treatment |
4 |
|
analysis of variance |
3 |
|
atherosclerosis |
3 |
|
biocompatible materials |
3 |
|
bone substitutes |
3 |
|
c-reactive protein |
3 |
|
case–control study |
3 |
|
chronic disease |
3 |
|
clinical trials, controlled |
3 |
|
collagen |
3 |
|
cone beam computed tomography |
3 |
|
ct imaging |
3 |
|
dental research |
3 |
|
diagnosis, clinical assessment |
3 |
|
disease progression |
3 |
|
enamel matrix derivative |
3 |
|
experimental gingivitis |
3 |
|
follow-up studies |
3 |
|
genetic susceptibility |
3 |
|
gingiva |
3 |
|
gingival recession |
3 |
|
guided tissue regeneration - methods |
3 |
|
health status disparities |
3 |
|
image processing, computer-assisted |
3 |
|
immunity |
3 |
|
implant dentistry |
3 |
|
implants |
3 |
|
infrabony defects |
3 |
|
local delivery |
3 |
|
maintenance |
3 |
|
masticatory function |
3 |
|
minerals |
3 |
|
molar extraction |
3 |
|
mucositis prevention |
3 |
|
peri-implant mucositis |
3 |
|
peri-implantitis prevention |
3 |
|
periapical radiograph |
3 |
|
periodontal diseases - complications - epidemiology |
3 |
|
periodontal diseases/surgery |
3 |
|
periodontal diseases/therapy |
3 |
|
periodontal healing |
3 |
|
periodontium |
3 |
|
peri‐implant defect |
3 |
|
peri‐implantitis/diagnosis |
3 |
|
pocket prevalence |
3 |
|
prosthetically driven implant placement |
3 |
|
radiographic bone loss |
3 |
|
radiology, imaging |
3 |
|
rats |
3 |
|
reproducibility of results |
3 |
|
root planing |
3 |
|
soft tissue |
3 |
|
statistics, nonparametric |
3 |
|
supportive care |
3 |
|
surgical flaps |
3 |
|
third molar surgery |
3 |
|
tooth extraction |
3 |
|
tooth survival |
3 |
|
transmucosal implant |
3 |
|
world health |
3 |
|
absorbable implants |
2 |
|
absorptiometry, photon |
2 |
|
absorptiometry, photon - methods |
2 |
|
acute periodontal conditions |
2 |
|
adherence |
2 |
|
administration, topical |
2 |
|
adolescent |
2 |
|
adult |
2 |
|
adverse events |
2 |
|
age factors |
2 |
|
aged |
2 |
|
aged, 80 and over |
2 |
|
alleles |
2 |
|
alveolar bone height |
2 |
|
alveolar bone loss - classification |
2 |
|
alveolar bone loss - diagnosis |
2 |
|
alveolar bone loss - drug therapy - radiography - therapy |
2 |
|
alveolar bone loss - etiology |
2 |
|
alveolar bone loss - etiology - genetics |
2 |
|
alveolar bone loss - etiology - radiography |
2 |
|
alveolar bone loss - radiography - surgery |
2 |
|
alveolar bone loss - surgery |
2 |
|
alveolar process - drug effects - radiography |
2 |
|
alveolar process - radiography |
2 |
|
alveolar ridge augmentation |
2 |
|
anti-bacterial agents - administration & dosage - therapeutic use |
2 |
|
anti-infective agents, local - administration & dosage - therapeutic use |
2 |
|
antigens, cd - analysis |
2 |
|
antigens, cd31 |
2 |
|
antigens, differentiation, myelomonocytic - analysis |
2 |
|
antigens, differentiation, myelomonocytic - immunology |
2 |
|
antigens, differentiation, t-lymphocyte |
2 |
|
antigens, neoplasm - analysis - genetics |
2 |
|
apoptosis - immunology |
2 |
|
artifacts |
2 |
|
b-lymphocytes - cytology |
2 |
|
bacteria |
2 |
|
bacteria, anaerobic - growth & development |
2 |
|
bacterial infections - immunology - pathology |
2 |
|
base sequence |
2 |
|
bicuspid - pathology |
2 |
|
biocompatible materials - therapeutic use |
2 |
|
biofilms |
2 |
|
biological complications |
2 |
|
biopsy |
2 |
|
bleeding on brushing |
2 |
|
blood flow |
2 |
|
bone density |
2 |
|
bone density - drug effects |
2 |
|
bone fill |
2 |
|
bone induction |
2 |
|
bone loss |
2 |
|
bone regeneration - drug effects |
2 |
|
bone replacement graft |
2 |
|
bone substitutes - pharmacology |
2 |
|
cardiovascular disease |
2 |
|
cd4-cd8 ratio |
2 |
|
cd4-positive t-lymphocytes - cytology |
2 |
|
cd8-positive t-lymphocytes - cytology |
2 |
|
cell adhesion molecules |
2 |
|
cell adhesion molecules - immunology |
2 |
|
cell count |
2 |
|
chemokine ccl2 |
2 |
|
chemotactic factors - genetics |
2 |
|
chi-square distribution |
2 |
|
chlorhexidine - administration & dosage - therapeutic use |
2 |
|
chronic periodontitis |
2 |
|
citrates |
2 |
|
classification |
2 |
|
clinical monitoring |
2 |
|
clinical study |
2 |
|
clinical trials |
2 |
|
clinical trials as topic |
2 |
|
cohort studies |
2 |
|
collagenases - analysis - biosynthesis - genetics |
2 |
|
colony count, microbial |
2 |
|
combined modality therapy |
2 |
|
comprehensive dental care |
2 |
|
computer assisted densitometric image analysis (cadia) |
2 |
|
congresses as topic |
2 |
|
connective tissue - immunology - pathology |
2 |
|
connective tissue cells |
2 |
|
consensus development conferences as topic |
2 |
|
controlled clinical trial |
2 |
|
cytokines |
2 |
|
cytokines - genetics |
2 |
|
dental enamel proteins |
2 |
|
dental enamel proteins - pharmacology |
2 |
|
dental implantation, endosseous |
2 |
|
dental implantation, endosseous - adverse effects |
2 |
|
dental implants - adverse effects |
2 |
|
dental implants - adverse effects - microbiology |
2 |
|
dental implants - complications. |
2 |
|
dental papilla - surgery |
2 |
|
dental plaque - diagnosis |
2 |
|
dental plaque index |
2 |
|
dental prophylaxis |
2 |
|
dental prosthesis design |
2 |
|
dental restoration failure |
2 |
|
dentures |
2 |
|
deproteinized bovine bone |
2 |
|
diabetes complications |
2 |
|
dietary diversity |
2 |
|
differentiation factors |
2 |
|
digital image analysis |
2 |
|
digital subtraction radiography |
2 |
|
disease susceptibility |
2 |
|
dna damage |
2 |
|
dna primers |
2 |
|
dna, bacterial - analysis |
2 |
|
doxycycline |
2 |
|
doxycycline - administration & dosage - therapeutic use |
2 |
|
drug implants |
2 |
|
dynamic navigation |
2 |
|
e-selectin |
2 |
|
edema - etiology |
2 |
|
endo-periodontal lesion |
2 |
|
endothelium |
2 |
|
endothelium, vascular - immunology |
2 |
|
epidemiologic methods |
2 |
|
epithelial attachment - blood supply - immunology |
2 |
|
epithelial cells |
2 |
|
epithelium |
2 |
|
epithelium - immunology - pathology |
2 |
|
etiology |
2 |
|
europe |
2 |
|
evaluation studies as topic |
2 |
|
extracellular matrix - enzymology |
2 |
|
extraction socket |
2 |
|
female |
2 |
|
fibre retention osseous resective surgery |
2 |
|
free hand |
2 |
|
furcation defects - diagnosis |
2 |
|
furcation defects - therapy |
2 |
|
gels |
2 |
|
gene expression regulation |
2 |
|
gene expression regulation, enzymologic |
2 |
|
gene frequency |
2 |
|
gene polymorphism |
2 |
|
genes |
2 |
|
genetic |
2 |
|
genetic polymorphisms |
2 |
|
genetic predisposition to disease |
2 |
|
genetic variation - genetics |
2 |
|
genotype |
2 |
|
gingiva - cytology |
2 |
|
gingiva - immunology - pathology |
2 |
|
gingiva - surgery |
2 |
|
gingival fluid |
2 |
|
gingival hemorrhage - classification |
2 |
|
gingival hemorrhage - diagnosis |
2 |
|
gingival hemorrhage - drug therapy - therapy |
2 |
|
gingival hemorrhage - therapy |
2 |
|
gingival recession - therapy |
2 |
|
gingivitis - epidemiology - genetics - therapy |
2 |
|
gingivitis - etiology - immunology |
2 |
|
gingivitis - immunology - microbiology - pathology |
2 |
|
gingivitis - immunology - pathology |
2 |
|
gingivitis - metabolism - pathology |
2 |
|
guided tissue regeneration, periodontal |
2 |
|
guided tissue regeneration, periodontal - adverse effects - methods |
2 |
|
haplotypes |
2 |
|
health status |
2 |
|
healthy aging |
2 |
|
homing receptors |
2 |
|
host-pathogen interactions |
2 |
|
humans |
2 |
|
il-1 gene polymorphism |
2 |
|
il-1 genotype |
2 |
|
immediate implant placement |
2 |
|
immediate implants |
2 |
|
immunoenzyme techniques |
2 |
|
immunohistochemistry |
2 |
|
immunologic memory |
2 |
|
immunophenotyping |
2 |
|
implant failure |
2 |
|
implant survival |
2 |
|
in situ nick-end labeling - methods |
2 |
|
infrabony defect |
2 |
|
integrins - analysis - genetics |
2 |
|
intercellular adhesion molecule-1 - immunology |
2 |
|
interleukin-1 |
2 |
|
interleukin-1 - genetics |
2 |
|
interleukin-1 polymorphism |
2 |
|
interleukin-1alpha - genetics |
2 |
|
interleukin-1beta - genetics |
2 |
|
interleukin-6 |
2 |
|
interleukin-8 - analysis - genetics |
2 |
|
interleukin-8 - genetics |
2 |
|
interleukin‐8 |
2 |
|
intra-bony defects |
2 |
|
intrabony defect |
2 |
|
intra‐bony |
2 |
|
jaw, edentulous - radiography |
2 |
|
keratins |
2 |
|
ki-67 antigen - analysis |
2 |
|
lactic acid - therapeutic use |
2 |
|
laser doppler flowmetry |
2 |
|
leukocyte count |
2 |
|
leukocytes, mononuclear - cytology |
2 |
|
linear models |
2 |
|
local antibiotics |
2 |
|
local drug delivery |
2 |
|
long term effects |
2 |
|
longitudinal studies |
2 |
|
lymphocyte count |
2 |
|
machine vision |
2 |
|
macrophages - cytology |
2 |
|
mandible - radiography |
2 |
|
mandible - surgery |
2 |
|
masticatory function and nutrition |
2 |
|
matched-pair analysis |
2 |
|
matrix metalloproteinase 3 |
2 |
|
matrix metalloproteinase 8 |
2 |
|
matrix metalloproteinases |
2 |
|
mechanical debridement |
2 |
|
membrane glycoproteins - analysis - genetics |
2 |
|
metagenome |
2 |
|
metalloendopeptidases - analysis - biosynthesis - genetics |
2 |
|
mhealth |
2 |
|
microbiota |
2 |
|
microsurgery |
2 |
|
middle aged |
2 |
|
minerals - pharmacology |
2 |
|
minerals - therapeutic use |
2 |
|
molar - pathology |
2 |
|
molar furcation |
2 |
|
molecular sequence data |
2 |
|
monocytes - cytology |
2 |
|
morbidity |
2 |
|
mouth mucosa - cytology |
2 |
|
mouth mucosa - immunology |
2 |
|
mouthwashes - therapeutic use |
2 |
|
mucositis |
2 |
|
multi-center studies |
2 |
|
multi-functional risk model |
2 |
|
multiple gingival recessions |
2 |
|
multivariate analysis |
2 |
|
muscles - drug effects |
2 |
|
muscular diseases - etiology |
2 |
|
necrotizing gingivitis |
2 |
|
necrotizing periodontitis |
2 |
|
neutrophils - cytology |
2 |
|
neutrophils - immunology |
2 |
|
neutrophils - physiology |
2 |
|
nutritional status |
2 |
|
nutrition—clinical |
2 |
|
older adults |
2 |
|
oral rinse |
2 |
|
oral surgical procedures - adverse effects - methods |
2 |
|
oral surgical procedures - methods |
2 |
|
osseointegration |
2 |
|
osseointegration - physiology |
2 |
|
osseous defect |
2 |
|
ossification, heterotopic - etiology |
2 |
|
osteogenesis - physiology |
2 |
|
outcome and process assessment (health care) |
2 |
|
outcome assessment (health care) |
2 |
|
patient care planning |
2 |
|
patient compliance |
2 |
|
patient outcomes |
2 |
|
patient satisfaction |
2 |
|
patient-centered outcomes |
2 |
|
peri-implant infection |
2 |
|
periodontal abscess |
2 |
|
periodontal attachment loss - classification |
2 |
|
periodontal attachment loss - surgery |
2 |
|
periodontal attachment loss - therapy |
2 |
|
periodontal diseases - classification - etiology - therapy |
2 |
|
periodontal diseases - diagnosis |
2 |
|
periodontal diseases - diagnosis - pathology - prevention & control |
2 |
|
periodontal diseases - diagnosis - pathology - therapy |
2 |
|
periodontal diseases - epidemiology |
2 |
|
periodontal diseases - microbiology - therapy |
2 |
|
periodontal index |
2 |
|
periodontal infection |
2 |
|
periodontal maintenance |
2 |
|
periodontal medicine |
2 |
|
periodontal pocket |
2 |
|
periodontal pocket - classification |
2 |
|
periodontal pocket - diagnosis |
2 |
|
periodontal pocket - drug therapy - radiography - therapy |
2 |
|
periodontal pocket - microbiology |
2 |
|
periodontal pocket - pathology - prevention & control |
2 |
|
periodontal pocket - surgery |
2 |
|
periodontal pocket - therapy |
2 |
|
periodontal risk assessment |
2 |
|
periodontics |
2 |
|
periodontics - instrumentation |
2 |
|
periodontics - instrumentation - trends |
2 |
|
periodontitis - complications - therapy |
2 |
|
periodontitis - drug therapy - microbiology - radiography - therapy |
2 |
|
periodontitis - enzymology - genetics |
2 |
|
periodontitis - epidemiology - genetics - therapy |
2 |
|
periodontitis - etiology |
2 |
|
periodontitis - etiology - genetics |
2 |
|
periodontitis - etiology - therapy |
2 |
|
periodontitis - genetics - therapy |
2 |
|
periodontitis - immunology - pathology - therapy |
2 |
|
periodontitis - metabolism |
2 |
|
periodontitis - prevention & control - therapy |
2 |
|
periodontitis - surgery |
2 |
|
periodontitis - therapy |
2 |
|
periodontium - drug effects - radiography |
2 |
|
periodontium - radiography |
2 |
|
periodorital disease |
2 |
|
perndontitis |
2 |
|
phagocytes - physiology |
2 |
|
pharmacokinetics |
2 |
|
phenotype |
2 |
|
point-of-care |
2 |
|
polyesters |
2 |
|
polyglycolic acid - therapeutic use |
2 |
|
polymerase chain reaction |
2 |
|
polymers - therapeutic use |
2 |
|
polymorphism, genetic |
2 |
|
polymorphism, genetic - genetics |
2 |
|
polymorphisms |
2 |
|
porphyromonas gingivalis - drug effects - growth & development |
2 |
|
predictive value of tests |
2 |
|
prospective studies |
2 |
|
prosthesis-related infections - etiology - genetics |
2 |
|
prosthesis-related infections - etiology - therapy |
2 |
|
proto-oncogene proteins c-bcl-2 - analysis |
2 |
|
psoriasis - immunology - pathology |
2 |
|
public health policy |
2 |
|
quality of life |
2 |
|
questionnaires |
2 |
|
radiographic diagnosis |
2 |
|
radiographic image enhancement |
2 |
|
radiographic image interpretation, computer-assisted |
2 |
|
radiography, bitewing |
2 |
|
radiography, dental |
2 |
|
radiography, dental - methods |
2 |
|
random allocation |
2 |
|
randomised controlled clinical trial |
2 |
|
randomized control trial (rct) |
2 |
|
rats, wistar |
2 |
|
rct |
2 |
|
receptors, lymphocyte homing - analysis - genetics |
2 |
|
receptors, lymphocyte homing - analysis - immunology |
2 |
|
recurrence |
2 |
|
recurrent periodontitis |
2 |
|
regression analysis |
2 |
|
reinfection |
2 |
|
residual pockets |
2 |
|
retreatment |
2 |
|
retrospective studies |
2 |
|
rfa |
2 |
|
risk evaluation |
2 |
|
rna, messenger - analysis |
2 |
|
rna, messenger - genetics |
2 |
|
saliva |
2 |
|
sex factors |
2 |
|
silver |
2 |
|
single-blind method |
2 |
|
skull - surgery |
2 |
|
slow release |
2 |
|
smoking - adverse effects |
2 |
|
smoking - epidemiology - genetics |
2 |
|
spain |
2 |
|
subtraction radiography |
2 |
|
subtraction technique |
2 |
|
supportive periodontal therapy |
2 |
|
supportive periodontal treatment |
2 |
|
supportive therapy |
2 |
|
surgical flaps - adverse effects |
2 |
|
surgical wound dehiscence - etiology |
2 |
|
swine |
2 |
|
systemic inflammation |
2 |
|
t lymphocytes |
2 |
|
t-lymphocyte subsets - cytology |
2 |
|
t-lymphocyte subsets - immunology - pathology |
2 |
|
t-lymphocytes - cytology |
2 |
|
t-lymphocytes - immunology - pathology |
2 |
|
t-lymphocytes, helper-inducer - immunology - pathology |
2 |
|
tapered implants |
2 |
|
tetracycline - administration & dosage - therapeutic use |
2 |
|
tissue engineering |
2 |
|
titanium |
2 |
|
tooth extraction - statistics & numerical data |
2 |
|
tooth loss - classification |
2 |
|
tooth loss - etiology |
2 |
|
tooth loss - prevention & control |
2 |
|
tooth mobility - physiopathology |
2 |
|
tooth socket - surgery |
2 |
|
topical subgingival doxycycline |
2 |
|
transmucosal healing |
2 |
|
transplantation, heterologous - methods |
2 |
|
treatment outcome |
2 |
|
tumor markers, biological - analysis - genetics |
2 |
|
tumor suppressor protein p53 - analysis |
2 |
|
vascular cell adhesion molecule-1 |
2 |
|
wound healing - drug effects |
2 |
|
wound healing - physiology |
2 |
|
xenograft |
2 |
|
β7 integrin |
2 |
|
access flap |
1 |
|
adherence/treatment |
1 |
|
ageing |
1 |
|
aggregatibacter actinomycetemcomitans |
1 |
|
alveolar ridge preservation |
1 |
|
amelogenins |
1 |
|
animal study |
1 |
|
anti thrombotic therapy |
1 |
|
antibiotics |
1 |
|
antimicrobial agent |
1 |
|
antimicrobials |
1 |
|
artificial membranes |
1 |
|
association |
1 |
|
bacteremia |
1 |
|
bateremia |
1 |
|
behavioural changes |
1 |
|
bibliometrics |
1 |
|
biological carriers |
1 |
|
biomarkers |
1 |
|
bioresorbable barrier membranes |
1 |
|
bisphosphonates |
1 |
|
bone |
1 |
|
bone grafting |
1 |
|
bone loss/periodontal |
1 |
|
bone loss/prevention and control |
1 |
|
bone loss/therapy |
1 |
|
butyrates |
1 |
|
c reactive protein |
1 |
|
calorimetry |
1 |
|
cardiovascular diseases |
1 |
|
cardiovascular risk |
1 |
|
case definition |
1 |
|
causality |
1 |
|
cell migration |
1 |
|
cell movement |
1 |
|
cell-binding domain bacterial adhesion |
1 |
|
cells |
1 |
|
characterization |
1 |
|
chlorhexidine |
1 |
|
cholesterol |
1 |
|
chronic inflammation |
1 |
|
clinical attachment level |
1 |
|
clinical attachment loss |
1 |
|
clinical guideline |
1 |
|
clinical guidelines |
1 |
|
clinical outcomes |
1 |
|
clinical studies |
1 |
|
clinical trials, randomized |
1 |
|
coagulation |
1 |
|
comparison studies |
1 |
|
complications |
1 |
|
complications/adverse events |
1 |
|
connective tissue diseases |
1 |
|
consensus report |
1 |
|
consensus statement |
1 |
|
conservative surgery |
1 |
|
controlled clinical trials |
1 |
|
cost analysis |
1 |
|
crp |
1 |
|
cystatin c |
1 |
|
cytoskeleton |
1 |
|
c‐reactive protein |
1 |
|
dehiscence defects |
1 |
|
delivery systems |
1 |
|
dental caries |
1 |
|
dependency |
1 |
|
drug delivery |
1 |
|
dyslipidemia |
1 |
|
emd |
1 |
|
emdogain |
1 |
|
enamel matrix |
1 |
|
enamel matrix derivatives |
1 |
|
endochondral bone grafts |
1 |
|
endothelial cell activation |
1 |
|
endotoxin-challenge |
1 |
|
evidence based dentistry |
1 |
|
evidence-based dentistry |
1 |
|
evidence-based periodontology |
1 |
|
experimental model |
1 |
|
exploratory analysis |
1 |
|
extent |
1 |
|
family study |
1 |
|
fcγ receptors |
1 |
|
fibre retention |
1 |
|
fibrillin |
1 |
|
fibrin |
1 |
|
fibroblasts |
1 |
|
fibronectin |
1 |
|
fixed partial dentures |
1 |
|
frailty |
1 |
|
free gingival graft |
1 |
|
furcation defects |
1 |
|
gene arrays |
1 |
|
generalized aggressive periodontitis |
1 |
|
genetic linkage |
1 |
|
genetics |
1 |
|
gerodontology |
1 |
|
gestational diabetes |
1 |
|
grade |
1 |
|
grade a periodontitis |
1 |
|
grade b periodontitis |
1 |
|
grade c periodontitis |
1 |
|
grafts, bone |
1 |
|
granulocyte |
1 |
|
gtr |
1 |
|
hba1c |
1 |
|
health economics |
1 |
|
health policy |
1 |
|
hopeless tooth |
1 |
|
human research |
1 |
|
hydrogen ion concentration |
1 |
|
hydrogen-ion concentration |
1 |
|
icam-1 |
1 |
|
il-6 |
1 |
|
impact factor |
1 |
|
implant outcomes |
1 |
|
implant performance |
1 |
|
implant placement/timing |
1 |
|
in vitro |
1 |
|
in vitro adsorption |
1 |
|
infection |
1 |
|
inflammatory burden |
1 |
|
inflammatory model |
1 |
|
insulin resistance |
1 |
|
interleukin-1 receptor antagonist |
1 |
|
interleukin-8 |
1 |
|
keratinized tissue |
1 |
|
keratinocytes |
1 |
|
long term |
1 |
|
long-term |
1 |
|
long-term care |
1 |
|
long-term effects |
1 |
|
maintenance care |
1 |
|
marfan syndrome |
1 |
|
membranes, bioabsorbable |
1 |
|
membranes/artificial |
1 |
|
membranes/barrier |
1 |
|
membranous bone grafts |
1 |
|
metaanalysis |
1 |
|
metabolic syndrome |
1 |
|
metabolism |
1 |
|
meta‐analysis |
1 |
|
microbiology |
1 |
|
minimally important difference |
1 |
|
minimally invasive surgery |
1 |
|
monkeys |
1 |
|
mouthrinses |
1 |
|
multicenter studies |
1 |
|
myocardial infarction |
1 |
|
nadph oxidase |
1 |
|
neutrophils |
1 |
|
nutrition |
1 |
|
obesity |
1 |
|
observational research |
1 |
|
occlusal membranes |
1 |
|
old myocardial infarction |
1 |
|
older people |
1 |
|
open access |
1 |
|
oral manifestations |
1 |
|
oral mucosa |
1 |
|
osseous defects |
1 |
|
osseous resective therapy |
1 |
|
ostecalcin |
1 |
|
osteoblasts |
1 |
|
osteogain |
1 |
|
osteoprotegerin |
1 |
|
outcome assessment |
1 |
|
outcomes |
1 |
|
overweight |
1 |
|
oxygen radicals |
1 |
|
pain |
1 |
|
papilla preservation flap |
1 |
|
perception |
1 |
|
periodontal access flap |
1 |
|
periodontal attachment loss |
1 |
|
periodontal attachment loss/prevention and control |
1 |
|
periodontal disease/therapy |
1 |
|
periodontal flap surgery |
1 |
|
periodontal ligament |
1 |
|
periodontal pockets/diagnosis |
1 |
|
periodontal probes |
1 |
|
periodontal re-generation |
1 |
|
periodontal support |
1 |
|
periodontal wafers |
1 |
|
periodontistis/definition |
1 |
|
periodontitis as manifestation of systemic disease |
1 |
|
periodontitis grading |
1 |
|
periodontitis staging |
1 |
|
periodontitis/diagnosis |
1 |
|
periodontitis/etiology |
1 |
|
periodontitis/grade |
1 |
|
periodontitis/stage |
1 |
|
periodontitis/surgery |
1 |
|
periodontitis/therapy |
1 |
|
peri‐implantitis |
1 |
|
phagocytes |
1 |
|
platelet-rich plasma |
1 |
|
polytetrafluoroethylene |
1 |
|
post-surgical protocols |
1 |
|
progression |
1 |
|
prophylaxis |
1 |
|
proteins, enamel matrix/therapeutic use |
1 |
|
prp |
1 |
|
public health |
1 |
|
quality of reporting |
1 |
|
quantitative analysis |
1 |
|
randomized clinical trials |
1 |
|
randomized controlled trial |
1 |
|
randomized- controlled clinical trial |
1 |
|
randomized-controlled trial |
1 |
|
responsiveness |
1 |
|
retrospective study |
1 |
|
review |
1 |
|
review/tutorial |
1 |
|
ridge augmentation |
1 |
|
root caries |
1 |
|
roughness |
1 |
|
scaling |
1 |
|
scientific publishing |
1 |
|
senescence |
1 |
|
silver nitrate |
1 |
|
sinus augmentation |
1 |
|
sinus graft |
1 |
|
smoking cessation |
1 |
|
stage |
1 |
|
stage i periodontitis |
1 |
|
stage ii periodontitis |
1 |
|
stage iii periodontitis |
1 |
|
stage iv periodontitis |
1 |
|
staining |
1 |
|
standard of care |
1 |
|
staphylococcus aureus |
1 |
|
stroke |
1 |
|
supportive periodontal care |
1 |
|
suprabony defects |
1 |
|
surface treatments |
1 |
|
surgery |
1 |
|
survival analysis |
1 |
|
tetracydine |
1 |
|
tissue graft |
1 |
|
tooth hypermobility |
1 |
|
tooth loss/prevention and control |
1 |
|
tooth vitality |
1 |
|
treated periodontitis |
1 |
|
vcg diagnosis |
1 |
|
vitamin d receptor |
1 |
|
would healing |
1 |
